Sign in
Taking people in United StatesNo phase

Treating Insomnia to Help Diabetes Care in Primary Clinics

Tests cognitive behavioral therapy for insomnia in adults with type 2 diabetes and poor sleep.

Key facts

Who runs it
Tulane University
Where
Zachary, United StatesSee the site
Trial code
Registry title
Enhancing Diabetes Care by Treating Insomnia
Status
Recruiting
People taking part
30 people, planned
Started
1 Sept 2026
Expected to end
30 Jun 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Cognitive Behavioral Therapy for Insomnia
  • Usual care for diabetes management
  • Usual care for treatment of insomnia
Record updated
2 September 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 40 or older with type 2 diabetes that is not well controlled and with insomnia. It tests a 6-week talking therapy for insomnia.

Age
40 years or older
Sex
All sexes can join
Disease stage
Type 2 diabetes with the most recent HbA1c above 7% (53 mmol/mol) within the past year, and an Insomnia Severity Index (ISI) score of 15 or higher
Biomarker or test result
HbA1c above 7% (53 mmol/mol); ISI score of 15 or higher

Main reasons for not taking part

  • Diagnosed or self-reported sleep apnea
  • Pregnant or planning to become pregnant during the study
  • A psychiatric or medical condition that would interfere with study procedures
  • Taking part in another diabetes clinical trial
  • Living in the same household as another participant

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • aged 40 or older
  • receive primary care from participating clinic
  • diagnosis of type 2 diabetes
  • most recent hemoglobin A1c (HbA1c) >7% within the past year
  • Insomnia Severity Index (ISI) score ≥15
  • able to speak English

Who cannot take part

  • having a psychiatric or medical condition that would interfere with the ability to complete study procedures
  • participating in another diabetes clinical trial
  • diagnosed or self-reported sleep apnea
  • pregnant or planning to become pregnant during the study period
  • living in same household as another participant
  • required to work night shifts

Where in United States

  • Southeast Community Health SystemsZachary, United StatesContact: Erin Peacock, PhD, MPHTaking people

About the trial

What the trial wants to find out

Insomnia is highly prevalent in individuals with type 2 diabetes (T2D) and is associated with poor glycemic control. Louisiana has one of the highest diabetes prevalence rates in the U.S., with significant disparities by race, income, and rural residence. Despite growing recognition of sleep's role in diabetes management, sleep disturbances remain largely unaddressed in diabetes care. Cognitive behavioral therapy for insomnia (CBT-I) is the first-line treatment for chronic insomnia, yet it is underutilized in primary care clinics such as federally qualified health centers (FQHCs) that serve high-risk populations.

Read full original descriptionShow less

The long-term goal of this research is to improve cardiometabolic health and reduce diabetes disparities by integrating sleep interventions into diabetes care. This pilot study aims to: (1) evaluate the impact of CBT-I on sleep and diabetes-related outcomes, and (2) assess the acceptability, feasibility, and fidelity of implementing a 6-week CBT-I program in an FQHC setting.

The investigators will conduct a randomized controlled trial (RCT) with 30 FQHC patients (aged 40+) with uncontrolled T2D (HbA1c >7%) and comorbid insomnia (Insomnia Severity Index (ISI) score ≥15). Participants will be randomly assigned to either the CBT-I intervention or usual care. Sleep (ISI scores, actigraphy) and cardiometabolic (HbA1c, fasting glucose, insulin) outcomes will be assessed at baseline and three months post-randomization. Implementation success will be evaluated using fidelity, feasibility, and acceptability measures. Findings will provide preliminary evidence for integrating CBT-I into primary care, informing larger trials to improve diabetes outcomes and reduce disparities in Louisiana.

The 2 groups in the trial

  • Cognitive Behavioral Therapy for InsomniaTreatment being tested

    Treatment: Cognitive Behavioral Therapy for Insomnia, Usual care for diabetes management, and Usual care for treatment of insomnia

  • Usual CareExisting treatment, for comparison

    Treatment: Usual care for diabetes management and Usual care for treatment of insomnia

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Enhancing Diabetes Care: Implementing Cognitive Behavioral Therapy for Insomnia to Improve Sleep and Cardiometabolic Outcomes
Plain-language title
Treating Insomnia to Help Diabetes Care in Primary ClinicsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
2 September 2026